10x Genomics, Inc. (TXG)

10x Genomics, Inc. (TXG) scores 58 out of 100 on boothcheck's 11-model valuation framework. Verdict: Hold The estimated fair value is $2.74, representing a 542% premium to fair value.

Analysis includes bear, base, and bull fair value targets using DCF, Graham, regression, and 8 other valuation models.

View full TXG analysis on boothcheck